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Abstract: The French paradox describes a lower incidence of cardiovascular problems despite a high
intake of saturated fats. This phenomenon was associated with higher consumption of red wine,
as it was later discovered that the presence of antioxidants, including resveratrol, have beneficial
effects. We hypothesized that resveratrol may have a more direct role in protection from harmful
oxidation, presumably through binding to important proteins of the blood coagulation process.
Spectrofluorimetry demonstrated that resveratrol is capable of binding to fibrinogen, the main
protein in the coagulation process, which is also important as a food additive. Various spectroscopic
methods determined that binding does not cause fibrinogen unfolding or destabilization since
protein melting temperature remains unchanged. A mutually protective effect against the free
radical-induced oxidation of polyphenol and fibrinogen was found. The presence of fibrinogen
caused only a negligible masking effect of the antioxidative abilities of resveratrol, measured by a
reduction of hexacyanoferrate (III), while greatly increasing its solubility in an aqueous environment,
thus increasing its potential bioavailability. Due to its interaction with fibrinogen, resveratrol may
serve as an antioxidant at the site of injury. The antioxidative effect of resveratrol may also protect
and thus keep the desired characteristics of fibrinogen during the application of this protein as a
food additive.
Keywords: resveratrol; fibrinogen; binding; antioxidant; solubility
1. Introduction
Resveratrol (3,5,4′-trihydroxystilbene) is a well-known molecule that belongs to the stilbene
group of polyphenols. Common sources of resveratrol are grapes, wine, peanuts, berries, and soy [1].
The idea that resveratrol may have beneficial effects on the cardiovascular system arose from the famous
French paradox, according to which French people have lower incidences of cardiovascular disease
(CVD) even though they consume a diet high in saturated fat [2]. In 2015, there were an estimated
422.7 million prevalent cases of cardiovascular diseases in the world. In the European Union (EU),
CVD represents the leading cause of mortality, and each year over 1.8 million deaths are associated
to CVD. From this number, there were 800,000 deaths in men and 1 million in women. The death
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proportion due to CVD in the EU ranges from 23% in France to 60% in Bulgaria in men, and from
25% in Denmark to 70% in Bulgaria in women. Ischemic heart disease (IHD) and strokes are the most
frequent CVDs. In the latest available report, France was reported to have the lowest age-standardized
death rate for IHD for both sexes, with 77 deaths per 100,000 in males and 32 deaths per 100,000 in
females. Since low- and middle-income countries have significantly higher IHD death rates compared
to high-income countries, these statistics should be treated with caution [3]. It was postulated that high
wine consumption in France offers protection against CVD. It was also reported that there is a general
association between decreased CVD incidence and mortality, and moderate alcohol consumption.
This effect is linked with insulin sensitivity and lipid metabolism, assuming the causal alcohol–CVD
association [4]. In 2015, almost three-quarters of French men consumed wine, compared to 60 per cent
of women, with per capita consumption at 7.09 L expressed as pure alcohol (with a decreasing trend
towards 2019). Later, it has been specified that the presence of resveratrol in wine is partially responsible
for its beneficial effects due to its potent antioxidative activity, among other actions [2]. Resveratrol is
well tolerated by humans and some studies report that plasma concentrations of this molecule can
reach up to 4 µM depending on the supplemental dosages. Different studies have measured different
concentrations of resveratrol in blood and they were found not to be in correlation with the initial
concentration of this molecule in the supplement formulation [5]. Different methods used for the
determination of resveratrol concentration also contribute to different values. Another important
consideration is that all of these papers published concentrations of resveratrol present in the blood,
while its actual concentration in tissues has still not fully been explored [5]. To put the role of
resveratrol into perspective, bioavailability and pharmacokinetic/pharmacodynamic modelling should
also be taken into account. When consumed orally, approximately 75% of resveratrol is absorbed.
It is thought that its absorption mainly occurs by transepithelial diffusion. A very important issue
concerning resveratrol is its bioavailability. The bioavailability of resveratrol is characterized by its
rapid elimination. While its absorption process is highly effective, free resveratrol is present at low
concentration in an organism due to the first hepatic step (first pass effect). Due to rapid metabolism in
intestine and liver, the bioavailability of resveratrol falls below 1%. Additionally, the absorption of
resveratrol is significantly delayed in the presence of food [6].
Plasma consists of over 100 proteins, the major ones being albumin, α-globulins, β-globulins,
γ-globulins and fibrinogen. Fibrinogen is a 340 kDa glycoprotein composed of three pairs of
chains with an (AαBβγ)2 structure [7] that circulates in the bloodstream at concentrations of 2 to
4 mg/mL (5.9–11.8 µM) [8]. Fibrinogen functions in the process of hemostasis, whereby during
blood vessel injury the aggregation of platelets occurs through the interaction of fibrinogen with
IIb/IIIa integrin on the surface of platelets, linking adjacent platelets and coagulating the blood
(primary hemostasis) [9]. During secondary hemostasis, fibrinogen is converted to fibrin by thrombin,
which removes fibrinopeptides A and B, forming fibrin monomers that associate with one another,
creating a fibrin network that serves to mechanically reinforce the blood clot [7]. Many factors influence
fibrin formation and, consequently, its degradation, including the types of fibrinogen chain [10],
the glycosylation of fibrin [11], and the interactions with other proteins [7] and small molecules [12].
Fibrinogen has also been applied as a food additive in combination with thrombin, and it belongs
to the category of food stabilizers [13,14]. For this application, both fibrinogen and thrombin are isolated
from healthy slaughtered animals, including porcine (Sus scrofa domesticus) and bovine (Bos taurus)
species that are consumed by humans. The meat industry uses the combination of thrombin and
fibrinogen for fresh meat reconstitution in order to obtain the desired size and form. In order to
do this, fibrin is formed from fibrinogen in the presence of thrombin. Thrombin hydrolyses fibrinogen
and creates fibrin monomers by proteolytic cleavage of fibrinopeptides A and B. The formed fibrin
monomers then polymerize and form a gel. The proteolytic action of thrombin also activates Factor XIII,
which covalently binds fibrin monomers. Following the series of steps, several cross-links are made
including fibrin–fibrin, fibrin–fibronectin, and fibrin–collagen. Due to the formation of cross-links and
the gelation of fibrin, strong bonds are made between meat pieces [15]. Toxicological tests are not
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required since both fibrinogen and thrombin are obtained from edible parts of animals. The production
of thrombin/fibrinogen enzyme preparation and its application as a food additive for reconstituting
food can be safely used as concluded by EFSA’s Scientific Panel on Food Additives, Flavorings,
Processing Aids and Materials in Contact with Food [13]. It is noteworthy that in low-pH products,
such as fermented sausages, fibrinogen may have deleterious effects on protein functionality [16].
An important modification that drastically influences fibrinogen function is its degree of
oxidation [17]. Fibrinogen is the blood protein that is most susceptible to oxidation [18], and its
oxidation has been liked to both thrombotic and bleeding complications in cardiovascular-related
diseases [19]. It is therefore attractive to investigate the ability of fibrinogen to bind molecules with
antioxidative potential and to study the effects of those interactions. It is known that bovine fibrinogen
spontaneously binds resveratrol with a binding constant of 1.11 × 104. However, this interaction leads
to conformational changes in fibrinogen secondary structure [20]. Having the French paradox in mind,
we hypothesized that one possible mechanism behind the beneficial effects of resveratrol lies in the
possible interaction of resveratrol with human fibrinogen and the subsequent protection of fibrinogen
from oxidation thanks to the potent antioxidative effect of resveratrol.
2. Materials and Methods
2.1. Materials
All chemicals used were of analytical grade. Human fibrinogen was purchased from Sigma
(Darmstadt, Germany) and further purified by dissolution in 50 mM phosphate buffer (pH 7.3),
followed by precipitation with a saturated ammonium sulfate solution (reaching a final concentration
of 25%), centrifugation and redissolution in the same buffer. This buffered solution of fibrinogen was
then used for all subsequent experiments. The purity of the obtained fibrinogen was determined using
reducing SDS-PAGE on 10% gel. Resveratrol was purchased from Carl Roth (Karlsruhe, Germany).
Stock solutions of resveratrol were prepared by dissolution in 100% ethanol; the final concentration of
ethanol was <2% in all experiments unless otherwise stated.
2.2. Spectrofluorometric Determination of the Fibrinogen/Resveratrol Affinity Constant
Spectrofluorometric analysis for determination of the affinity constant between fibrinogen and
resveratrol was performed using a FluoroMax®-4 spectrofluorometer (Horiba Scientific, Japan).
Fibrinogen (40 nM) was titrated with increasing concentrations of resveratrol (0–30 µM) at 25 ◦C.
The protein was excited at 280 nm (excitation wavelength for both Tyr and Trp residues) and emission
spectra were recorded from 290 to 450 nm (5 nm slit widths). The obtained fluorescence spectra
were corrected by subtracting the fluorescence originating from resveratrol itself for each tested
concentration. The change in the fibrinogen fluorescence intensity maximum at 345 nm was used to
calculate the affinity constant. This fluorescence intensity was corrected for the inner filter effect using
the following equation:
FC = F0 × 10(Aem + Aex)/2 (1)
where FC is the corrected fluorescence, F0 is the measured fluorescence, and Aem and Aex are the
absorbances at the wavelengths of the emission (345 nm) and excitation (280 nm) peaks, respectively.
For the determination of the quenching type, the Stern–Volmer (SV) quenching constant was
calculated according to the relationship [21]:
F0
F
= 1+ kqτ0[Q]= 1+KSV[Q] (2)
where F0 and F are protein fluorescence intensity at 345 nm without and with resveratrol, respectively;
kq is the quenching rate constant of the biomolecule; τ0 is the average lifetime of the biomolecule
without quencher (10−8 s); [Q] is the total quencher (resveratrol) concentration; and KSV is the SV
quenching constant. The slope of the SV plot represents the SV quenching constant.
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where F0 and F are the emission signals of fibrinogen in the absence and in the presence of the ligand
(resveratrol), respectively, while [L] and [P] represent the total concentrations of the ligand (resveratrol)
and the protein (fibrinogen), respectively.
In a separate experiment, resveratrol (10 µM) was excited at 320 nm and its emission spectra in the
absence and the presence of fibrinogen were recorded from 350 to 500 nm. Due to the large amounts of
fibrinogen that would be required, no titration of resveratrol with protein was performed, and only
one concentration of protein (10 µM) was used to demonstrate the consequence of complex formation
on resveratrol emission.
2.3. Determination of Temperature Stability of the Fibrinogen/Resveratrol Complex
The influence of resveratrol on fibrinogen thermal stability was analyzed using the same equipment
as described in Section 2.2. The temperature dependence of fibrinogen fluorescence, both alone (20 nM)
and in the presence of resveratrol (20 µM) was followed by increasing the temperature from 25 to
75 ◦C at a rate of 1 ◦C/min (the equilibration period was set to 1 min). The results are presented as
a ratio of the fluorescence intensities at 353 and 339 nm for the protein alone and at 363 and 349 nm
for the fibrinogen/resveratrol complex since the binding of resveratrol causes a bathochromic shift of
the fibrinogen emission maximum. As fibrinogen denaturation is characterized by a bathochromic
shift of its emission maximum as well, the applied method gave results that were fitted into sigmoidal
functions, with the inflection point representing the melting temperature of fibrinogen.
2.4. Analysis of Fibrinogen/Resveratrol Complex Formation Using Circular Dichroism (CD) Spectroscopy
The influence of fibrinogen/resveratrol complex formation on protein structure was investigated
by recording near-UV and far-UV Circular Dichroism (CD) spectra of fibrinogen alone (3 µM) and
fibrinogen in the presence of several resveratrol concentrations (5, 10, 15, 20, and 30 µM). The spectra
were recorded using a J-815 spectropolarimeter (Jasco, Japan) at room temperature with a scan speed
of 50 nm/min. The spectra were recorded from 260 to 320 nm (1 cm cell path) in the near-UV and from
185 to 260 nm (0.01 cm cell path) in the far-UV. The obtained spectra of fibrinogen in the presence of
resveratrol were corrected by subtracting the spectra of resveratrol obtained at each concentration
used, while the spectra of fibrinogen alone were corrected by subtracting the spectra of the buffer.
2.5. UV-VIS Analysis of Fibrinogen/Resveratrol Complex Formation
UV-VIS analysis was performed using a NanoDrop 2000c spectrophotometer (Thermo Scientific,
Waltham, MA, USA). Spectra of fibrinogen (3 µM) in the absence and presence of resveratrol (30 µM)
were recorded from 250 to 400 nm. In order to compare the spectral characteristics that originate from
the protein alone with that of fibrinogen in the presence of resveratrol, the spectra obtained only from
resveratrol were subtracted from the spectra of fibrinogen in the presence of resveratrol. A similar
data transformation was also performed to determine whether there is also a change in the resveratrol
spectra in the presence of fibrinogen; protein spectra were subtracted from the spectra of resveratrol in
the presence of fibrinogen.
2.6. Effect of Fibrinogen on Resveratrol Solubility
Whether the presence of fibrinogen influenced resveratrol solubility was analyzed following a
similar published procedure [22]. The samples for analysis consisted of 2 mM resveratrol in 13%
ethanol in the absence or presence of fibrinogen (9 µM). After 5 min at room temperature, the mixtures
were centrifuged at 10,000× g for 5 min and the supernatants were diluted 20-fold with a phosphate
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buffer. The amount of resveratrol present in the diluted supernatant was determined from the UV-VIS
absorbance spectra recorded from 250 to 400 nm using the molar extinction coefficient of resveratrol
(33,400 M−1 cm−1) at 312 nm.
2.7. Free Radical-Mediated Oxidation of Fibrinogen and Resveratrol
Fibrinogen oxidation induced by 2,2′-azobis(2-amidinopropane) dihydrochloride (AAPH) was
followed by measuring the intrinsic fluorescence decay of fibrinogen after excitation at 280 nm.
An aqueous AAPH solution was added to fibrinogen alone (100 nM) or to fibrinogen in the presence of
resveratrol (200 nM); the final concentration of AAPH was 2.5 mM. Immediately upon AAPH addition,
samples were placed in the spectrofluorometer and the fluorescence decay of fibrinogen at 345 nm was
measured (5 nm slit widths, 280 nm excitation). The obtained results were corrected by subtracting
the fluorescence contribution of resveratrol alone. The protective effect (PE), expressed in arbitrary




× 100 % (4)
where AUCFng+R represents the area under the curve obtained from oxidation of the
fibrinogen/resveratrol mixture, while AUCFng represents the area under the curve obtained from
oxidation of free fibrinogen.
To measure the free radical-mediated oxidation of resveratrol, UV-VIS spectroscopy was used to
monitor the decrease in the absorption maximum of resveratrol at 305 nm over time in the presence of
AAPH at 37 ◦C. To the resveratrol alone (15 µM), or in the presence of fibrinogen (7.5 µM), AAPH was
added for a final concentration of 10 mM. After AAPH addition, samples were immediately placed in
the UV-VIS spectrophotometer and the absorbance was monitored. Since a linear relationship was
observed, the results are expressed as a difference between the initial and final measured absorbance.
2.8. Total Reducing Power of Fibrinogen, Resveratrol, and Their Complex
The reducing power of fibrinogen (7.5 µM), resveratrol (15 µM), and fibrinogen/resveratrol
complex (7.5 µM fibrinogen and 15 µM resveratrol) samples was determined according to a published
method [23]. To 40 µL of the sample solution, 100 µL of 0.2 M phosphate buffer (pH 6.6) and 100 µL
of 1% potassium hexacyanoferrate (III) were added, followed by incubation at 50 ◦C for 20 min.
After incubation, 20% trichloroacetic acid was added and the reaction mixture was centrifuged at
10,000× g for 8 min. The supernatant (100 µL) was mixed with 100 µL of deionized water and 12 µL of
1% FeCl3. After equilibrating for 10 min at room temperature, the absorbance was measured at 670 nm.




× 100 % (5)
where AR and AFng+R are the measured absorbances at 670 nm in the absence and presence of
fibrinogen, respectively.
2.9. Statistical Analysis of Data
All presented data are given as mean results of at least three independent measurements.
Unless otherwise stated, they are all shown as means ± SD. For the comparison of data between two
groups of samples in our experiments, Student’s t-test was used. Where it was necessary to compare
three groups of data, a one-way ANOVA test was used. The results were considered significant if
p value was below 0.05.
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3. Results and Discussion
3.1. Binding Analysis of Fibrinogen and Resveratrol
Binding of resveratrol to fibrinogen quenches its intrinsic fluorescence in a dose-dependent
manner (Figure 1A), within the tested range of concentrations. From the SV plot (Supplementary data
Figure S1), and SV constant was calculated to be 4.4× 103 M−1 with bimolecular quenching rate constant
of 4.4× 1011 M−1, which is higher than the diffusion rates of biomolecules (1010 M−1 s−1) suggesting that
a static type of quenching of fibrinogen occurs in the presence of resveratrol. Fluorescence quenching
was used to determine the binding constant, Ka, which was calculated to be 2.58 ± 0.32 × 103 M−1
(Figure 1B). A significant bathochromic shift (10 nm when 30 µM of resveratrol is present) is also
observed in addition to a decrease in the fluorescence, suggesting that changes in the polarity of the
fluorophore environment occur upon resveratrol binding. The occurrence of a bathochromic shift in
the protein fluorescence suggests that there is a change in the environment of the Trp residues involved
in the intrinsic fluorescence of fibrinogen, resulting in their exposure to a more polar environment [24].
Additional evidence supporting the occurrence of an interaction between resveratrol and fibrinogen is
the nearly doubled intensity and significant hypsochromic shift (20 nm) of resveratrol fluorescence in
the presence of fibrinogen compared to resveratrol alone when excited at 320 nm (Figure 1C).
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residue in the fibrinogen molecule is increased upon interaction with resveratrol, which may suggest 
Figure 1. (A) Fluorescence e ission quenching of fibrinogen upon its excitation at 280 n in the
presence of increasing resveratrol concentrations. (B) A Stern–Volmer plot obtained from fluorescence
quenching data used for determination of the binding constant. (C) Resveratrol fluorescence emission
after its excitation at 320 nm with and without fibrinogen.
Both the increase in the intrinsic resveratrol fluorescence and hypsochromic shift indicate that
upon binding to fibrinogen, the environment polarity of resveratrol is reduced [25]. A similar effect
was observed upon the interaction of resveratrol with β-lactoglobulin [22]. UV-VIS spectrophotometry
reveals that fibrinogen absorbance at 280 nm decreases in the presence of resveratrol along with a small
hypsochromic shift (Figure 2A). Therefore the polarity of Trp side residue in the fibrinogen molecule is
Foods 2020, 9, 780 7 of 13
increased upon interaction with resveratrol, which may suggest partial exposure of the fluorophore
to the solvent due to unfolding of the protein. On the other hand, the presence of fibrinogen does
not alter the resveratrol UV-VIS absorbance spectrum (Figure 2B), meaning that applied UV-VIS
experimental conditions are not able to detect alterations of resveratrol environment as a consequence
of its interaction with fibrinogen.
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Figure 2. The effect of resveratrol on the UV-VIS spectra of fibrinogen (A). Overlapped UV-VIS spectra
of resveratrol alone and resveratrol in the presence of fibrinogen (B).
Similar melting temperatures were obtained for fibrinogen alone or in the presence of resveratrol
(Figure 3A,B), suggesting that resveratrol does not significantly (p > 0.05) affect fibrinogen folding
and stability. The melting temperature was 53.2 ± 0.6 ◦C for fibrinogen alone and 53.9 ± 0.48 ◦C
for fibrinogen in the presence of resveratrol, which was similar to previously published results [8].
This melting temperature corresponds to the melting of the terminal D regions of fibrinogen [26].
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of resveratrol.
3.2. Structural Analysis of Fibrinogen in Complex with Resveratrol
Although the results from spectrofluorometry and spectrophotometry may suggest some structural
alteration in fibrinogen structure upon resveratrol binding, far-UV and near-UV CD spectroscopy failed
to demonstrate any difference in both tertiary and secondary structures (Figure 4A,B). In the presence of
all tested resveratrol concentrations, the far-UV and near-UV CD spectra are nearly the same. It seems
that the amount of α-helixes, the most dominant secondary structure of fibrinogen, remains the same
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during resveratrol binding. Similar results were obtained when human fibrinogen was incubated with
bilirubin [12]. However, the interaction of resveratrol with bovine fibrinogen decreases the α-helical
content in the protein [20], suggesting that a different interaction mechanism occurs compared to
human fibrinogen. The binding of resveratrol to some bovine milk proteins (e.g., β-lactoglobulin and
β-casein) also did not have any significant effect on their secondary structure [27].
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Figure 4. The effect of increasing concentrations of resveratrol on the tertiary and secondary structure
of fibrinogen: (A) near-UV CD and (B) far-UV CD.
While it is already known that bovine fibrinogen is able to bind resveratrol [20], our results
investigated this interaction using fibrinogen of human origin. When compared, the results point to
some interesting differences. The affinity constant for human fibrinogen is lower almost by an order of
magnitude. No structural differences are observed for human fibrinogen in the presence of resveratrol,
which is not the case with bovine fibrinogen, where a reduction in the α-helical content of this protein
was observed. Although fibrinogens from human and bovine origin are homologous, it seems that
they are different enough to react differently with resveratrol.
3.3. Anti-Oxidative Effects of Fibrinogen/Resveratrol Complex
Under the experimental conditions tested, protection from AAPH-induced free radical oxidation
is mutual, whereby resveratrol is able to protect fibrinogen from oxidation, and vice versa. To measure
the protective effect of resveratrol on fibrinogen oxidation, we determined the area under the curves
obtained from the decrease in intrinsic fibrinogen fluorescence in the presence of AAPH. The measured
area under the curve (expressed in a.u.) in the presence of resveratrol was 6.1 ± 0.5, which was
significantly higher (p < 0.05) than the area under the curve for fibrinogen alone, which was 4.8 ± 1.8.
In the presence of resveratrol, the area was on average 27% larger compared to fibrinogen alone
(Figure 5A). It can clearly be seen from Figure 5A that in the presence of resveratrol, an initial short
lag phase is observed that is missing when only fibrinogen is present. The oxidation of resveratrol
displays a linear relationship over time (Figure 5B), allowing the results to be expressed as slopes.
As can be seen from Figure 5B, the slope of the linear graph obtained in the presence of fibrinogen
(k = −0.020 ± 0.000014) is not as steep as the slope for resveratrol alone (k = −0.026 ± 0.000292),
indicating that fibrinogen is capable of protecting resveratrol from free radical-induced oxidation.
The obtained slopes were significantly different (p < 0.05).
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i re 5. (A) The protective effect of resveratrol towards fibrinogen from 2,2′-azobis(2-amidinopr pane)
dihydrochloride (AAPH)-induce free radical oxidation measured by the fluorescence decay of
fibrinogen. (B) The protective effect of fibrinogen towards resveratrol from AAPH-induced free radical
oxidation measured by the reduction of resveratrol absorbance at 305 nm. (C) The effect of fibrinogen
on resveratrol solubility in an aqueous environment. (D) The reducing ability (absorbance) of free
fibrinogen, free resveratrol, and fibrinogen/resveratrol complex.
The results of this study suggest the possibility that the interaction of resveratrol with fibrinogen
protects resveratrol from oxidation, allowing it to reach the site of injury in its antioxidative form.
As a fibrin clot starts to assemble, resveratrol may either be initially released due to fibrin monomer
association or released later as a consequence of fibrin degradation by plasmin. In either scenario,
its antioxidative effect can be realized in close proximity to the injury, positively influencing the local
healing process.
Another important consequence of this interaction is the protection of the fibrinogen protein
itself. Extensive studies of fibrinogen oxidation indicate the detrimental effects of oxidation on its
function, including its involvement in many pathologic conditions that are characterized as having a
high risk for developing thrombotic complications. Thus far, both in vivo and in vitro studies have
shown that the oxidation of fibrinogen alters its coagulation properties, such as through the formation
of thinner fibrin fibers and the reduction of its porosity [28–30]. For instance, glyco-oxidation from
diabetes affects fibrinogen in such a way that activation of plasmin, a key protease for its degradation,
is impaired on the surface of fibrinogen [31]. As a consequence, all of these effects can alter fibrinogen
and make it more thrombogenic.
It is therefore important to study the interactions and effects of active food-derived components
that have antioxidative potential with fibrinogen. These components must protect fibrinogen from
harmful oxidation while also being benign or beneficial to its hemostatic function. Resveratrol does not
interfere with fibrinogen hemostatic properties, including both fibrin formation and fibrinolysis [32],
making it likely that its consumption will only have a positive protective effect on this protein.
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Another important aspect of resveratrol is its inhibitory effect on platelet activation, a phenomenon
that is present under inflammation conditions and oxidative stress [33].
Protecting fibrinogen through its interaction with bioactive food components may also be important
in its application as a food additive. In addition to protective antioxidative effect, these interactions
may also lead to the formation of fibrin gels with more desirable characteristics suitable for their usage
as food stabilisers.
Elevated fibrinogen levels in plasma are considered as a risk factor for poor prognosis in many
human diseases, and this protein is also designated as one of the damage-associated molecular pattern
(DAMPs) proteins. The consequences of an upregulated fibrinogen are yet to be elucidated, but the
impairment of mitochondria may be one of them. The amelioration of this effect is possible by
resveratrol, which is known to improve cell-dependent mitochondrial functions under in vitro and
in vivo conditions, including an increased mitochondrial bioenergetics. Moreover, an increased plasma
fibrinogen level is a prothrombotic factor. In non-alcoholic fatty liver disease (NAFLD), an upregulation
of a fibrinogen is an independent risk factor of CVD. Studies with trans-resveratrol have shown that
this polyphenol reduces the liver fat and hepatic enzymes such as glutamate pyruvic transaminase
(SGPT) and gamma-glutamyl transpeptidase (g-GT), and it also ameliorates insulin resistance, thus
preventing and reducing liver damage in NAFLD [34–37].
3.4. Effect of Fibrinogen on Resveratrol Solubility
Another very important aspect of any medication or food supplement is its bioavailability in
living systems. Because the solubility of resveratrol in aqueous environments such as blood is poor [38],
it is necessary that some mechanisms are present to transport it in the bloodstream or increase its
solubility while in circulation. For instance, cyclodextrins are able to form complexes with resveratrol
and increase its solubility in aqueous solutions while some were able to increase its light stability [39].
The experimental conditions described in Section 2.6 resulted in the formation of precipitates
from both reaction mixtures after equilibration for five minutes at room temperature, though more
precipitate was observed in the mixture without fibrinogen. After the centrifugation and dilution of the
supernatant, the UV-VIS spectra of the samples were recorded, whereby the absorbance of the mixture
that contained fibrinogen was twice as intense as the one without protein (Figure 5C), suggesting that
the presence of fibrinogen increases resveratrol solubility in an aqueous environment, thus increasing
its bioavailability. Thye measured concentration of resveratrol was 0.57 ± 0.012 mM in the absence
of fibrinogen and significantly higher (p < 0.05) in the presence of fibrinogen. It was calculated to be
1.13 ± 0.012 mM. A similar effect was observed for β-lactoglobulin [22].
3.5. Reducing Ability of Fibrinogen/Resveratrol Complex
Under the presented experimental conditions, fibrinogen itself is not capable of reducing
hexacyanoferrate (III), demonstrating that all antioxidative capabilities can be attributed to resveratrol
(Figure 5D). The masking effect is usually a normal consequence of protein-ligand interactions [23,40],
and it is characterized by lowering the antioxidative ability of bioactive ligands. While this may initially
seem like a negative consequence of the interaction, the degradation of a protein may release bound
ligand with its full antioxidative potential. The presence of fibrinogen creates a very small masking
effect on the reducing ability of resveratrol (8%). A statistical analysis indicated that this effect was not
significant (p > 0.05) as determined by a one-way ANOVA test. This means that resveratrol has almost
full antioxidative potential even when it is bound to fibrinogen. In addition, the initial interaction with
fibrinogen protects resveratrol, thus prolonging its bioactivity. Upon fibrinogen degradation, a fully
active resveratrol can be released.
4. Conclusions
Binding between fibrinogen and resveratrol was detected, and together they provide mutually
beneficial effects towards one another. This agrees with our hypothesis as one possible mechanistic
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insight into the famous French paradox that is characterized by the relatively few occurrences of
cardiovascular complications despite the consumption of a high-fat diet. Here, we have demonstrated
at the molecular level that a polyphenol of red wine, resveratrol, may bind and protect fibrinogen from
harmful oxidation. Fibrinogen also increases the solubility of resveratrol in aqueous environments
and provides protection from oxidation, thus increasing the bioavailability of resveratrol and its
antioxidant potential.
Supplementary Materials: The following are available online at http://www.mdpi.com/2304-8158/9/6/780/s1,
Figure S1: Stern-Volmer (SV) plot used to calculate SV constant and bimolecular quenching rate constant.
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